首页 | 本学科首页   官方微博 | 高级检索  
     


Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease
Authors:Hiroyuki Suzuki  Takashi Niizeki  Tomotake Shirono  Yusuke Koteda  Yoshinao Kinjyo  Naohisa Mizukami  Makoto Koda  Satoshi Ota  Masahito Nakano  Shusuke Okamura  Hideki Iwamoto  Shigeo Shimose  Yu Noda  Naoki Kamachi  Akira Kajiwara  Kenji Suda  Jun Akiba  Hirohisa Yano  Ryoko Kuromatsu  Hironori Koga  Takuji Torimura
Affiliation:1.Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan; 2.Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan; 3.Department of Pathology, Kurume University School of Medicine, Japan; 4.Kumamoto Radiosurgery Clinic, Japan; 5.Iwamoto Internal Medicine Clinic, Japan
Abstract:Fontan-associated liver disease (FALD) caused by long-term systemic venous congestion following the Fontan procedure may eventually lead to hepatocellular carcinoma (HCC). Treatment strategies for HCC due to FALD (FALD-HCC) remain unclear. We herein report a 35-year-old man with FALD-HCC that was well controlled by 3 cycles of continuous infusion of 5-fluorouracil and low-dose cisplatin (low-dose FP therapy) combined with 60 Gy of radiation therapy. However, the patient ultimately died of extrahepatic metastases. A pathological autopsy revealed more than 90% necrosis in the primary HCC lesion. This case suggests that low-dose FP therapy might be effective in FALD-HCC.
Keywords:Fontan-associated liver disease   hepatocellular carcinoma   low-dose FP therapy   radiation therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号